Literature DB >> 20060370

Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression.

Ivan O Potapenko1, Vilde D Haakensen, Torben Lüders, Aslaug Helland, Ida Bukholm, Therese Sørlie, Vessela N Kristensen, Ole C Lingjaerde, Anne-Lise Børresen-Dale.   

Abstract

Glycosylation is the stepwise procedure of covalent attachment of oligosaccharide chains to proteins or lipids, and alterations in this process have been associated with malignant transformation. Simultaneous analysis of the expression of all glycan-related genes clearly gives the advantage of enabling a comprehensive view of the genetic background of the glycobiological changes in cancer cells. Studies focusing on the expression of the whole glycome have now become possible, which prompted us to review the present knowledge on glycosylation in relation to breast cancer diagnosis and progression, in the light of available expression data from tumors and breast tissue of healthy individuals. We used various data resources to select a set of 419 functionally relevant genes involved in synthesis, degradation and binding of N-linked and O-linked glycans, Lewis antigens, glycosaminoglycans (chondroitin, heparin and keratan sulfate in addition to hyaluronan) and glycosphingolipids. Such glycans are involved in a number of processes relevant to carcinogenesis, including regulation of growth factors/growth factor receptors, cell-cell adhesion and motility as well as immune system modulation. Expression analysis of these glycan-related genes revealed that mRNA levels for many of them differ significantly between normal and malignant breast tissue. An associative analysis of these genes in the context of current knowledge of their function in protein glycosylation and connection(s) to cancer indicated that synthesis, degradation and adhesion mediated by glycans may be altered drastically in mammary carcinomas. Although further analysis is needed to assess how changes in mRNA levels of glycan genes influence a cell's glycome and the precise role that such altered glycan structures play in the pathogenesis of the disease, lessons drawn from this study may help in determining directions for future research in the rapidly-developing field of glycobiology. Copyright 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20060370      PMCID: PMC5527897          DOI: 10.1016/j.molonc.2009.12.001

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  121 in total

1.  Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium.

Authors:  Y J Kim; L Borsig; H L Han; N M Varki; A Varki
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

2.  Overexpression of lysosomal-type sialidase leads to suppression of metastasis associated with reversion of malignant phenotype in murine B16 melanoma cells.

Authors:  T Kato; Y Wang; K Yamaguchi; C M Milner; R Shineha; S Satomi; T Miyagi
Journal:  Int J Cancer       Date:  2001-06-15       Impact factor: 7.396

Review 3.  Regulation of integrin functions by N-glycans.

Authors:  Jianguo Gu; Naoyuki Taniguchi
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

Review 4.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

Authors:  Boudewijn J M Braakhuis; Maarten P Tabor; J Alain Kummer; C René Leemans; Ruud H Brakenhoff
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

5.  Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6).

Authors:  Y Fukushi; E Nudelman; S B Levery; S Hakomori; H Rauvala
Journal:  J Biol Chem       Date:  1984-08-25       Impact factor: 5.157

6.  Multiple forms of mammalian sialidase: altered expression in carcinogenesis.

Authors:  T Miyagi; K Hata; K Konno; S Tsuiki
Journal:  Tohoku J Exp Med       Date:  1992-10       Impact factor: 1.848

7.  Functional role of N-glycosylation in alpha 5 beta 1 integrin receptor. De-N-glycosylation induces dissociation or altered association of alpha 5 and beta 1 subunits and concomitant loss of fibronectin binding activity.

Authors:  M Zheng; H Fang; S Hakomori
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

8.  The activation of fibroblast growth factors (FGFs) by glycosaminoglycans: influence of the sulfation pattern on the biological activity of FGF-1.

Authors:  Jesús Angulo; Rafael Ojeda; José-Luis de Paz; Ricardo Lucas; Pedro M Nieto; Rosa M Lozano; Mariano Redondo-Horcajo; Guillermo Giménez-Gallego; Manuel Martín-Lomas
Journal:  Chembiochem       Date:  2004-01-03       Impact factor: 3.164

9.  Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain.

Authors:  Y Fukushi; S Hakomori; E Nudelman; N Cochran
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

10.  Multiple domains of the large fibroblast proteoglycan, versican.

Authors:  D R Zimmermann; E Ruoslahti
Journal:  EMBO J       Date:  1989-10       Impact factor: 11.598

View more
  63 in total

1.  Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.

Authors:  L Oliveira-Ferrer; M Kürschner; V Labitzky; D Wicklein; V Müller; G Lüers; U Schumacher; K Milde-Langosch; C Schröder
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-10       Impact factor: 4.553

2.  Exploiting topological constraints to reveal buried sequence motifs in the membrane-bound N-linked oligosaccharyl transferases.

Authors:  Marcie B Jaffee; Barbara Imperiali
Journal:  Biochemistry       Date:  2011-08-16       Impact factor: 3.162

3.  Chondroitin sulfate-mediated N-cadherin/β-catenin signaling is associated with basal-like breast cancer cell invasion.

Authors:  Satomi Nadanaka; Hiroki Kinouchi; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2017-11-28       Impact factor: 5.157

4.  Cell-Specific Variation in E-Selectin Ligand Expression among Human Peripheral Blood Mononuclear Cells: Implications for Immunosurveillance and Pathobiology.

Authors:  Mariana Silva; Ronald Kam Fai Fung; Conor Brian Donnelly; Paula Alexandra Videira; Robert Sackstein
Journal:  J Immunol       Date:  2017-03-22       Impact factor: 5.422

5.  Overexpression of α2,3sialyl T-antigen in breast cancer determined by miniaturized glycosyltransferase assays and confirmed using tissue microarray immunohistochemical analysis.

Authors:  Shilpa A Patil; Wiam Bshara; Carl Morrison; E V Chandrasekaran; Khushi L Matta; Sriram Neelamegham
Journal:  Glycoconj J       Date:  2014-10       Impact factor: 2.916

6.  Cytotoxic protein from the mushroom Coprinus comatus possesses a unique mode for glycan binding and specificity.

Authors:  Peilan Zhang; Kunhua Li; Guang Yang; Changqing Xia; Jane E Polston; Gengnan Li; Shiwu Li; Zhao Lin; Li-Jun Yang; Steven D Bruner; Yousong Ding
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

7.  Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.

Authors:  Daisy Sproviero; Sylvain Julien; Brian Burford; Joyce Taylor-Papadimitriou; Joy M Burchell
Journal:  J Biol Chem       Date:  2012-12-28       Impact factor: 5.157

Review 8.  Glycosylation in cancer: mechanisms and clinical implications.

Authors:  Salomé S Pinho; Celso A Reis
Journal:  Nat Rev Cancer       Date:  2015-08-20       Impact factor: 60.716

9.  Differential N-Glycosylation Patterns in Lung Adenocarcinoma Tissue.

Authors:  L Renee Ruhaak; Sandra L Taylor; Carol Stroble; Uyen Thao Nguyen; Evan A Parker; Ting Song; Carlito B Lebrilla; William N Rom; Harvey Pass; Kyoungmi Kim; Karen Kelly; Suzanne Miyamoto
Journal:  J Proteome Res       Date:  2015-09-30       Impact factor: 4.466

10.  Serum N-glycan analysis in breast cancer patients--Relation to tumour biology and clinical outcome.

Authors:  Vilde D Haakensen; Israel Steinfeld; Radka Saldova; Akram Asadi Shehni; Ilona Kifer; Bjørn Naume; Pauline M Rudd; Anne-Lise Børresen-Dale; Zohar Yakhini
Journal:  Mol Oncol       Date:  2015-08-19       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.